Literature DB >> 28473412

Alzheimer disease makes new blood contacts.

Mario Merlini1, Katerina Akassoglou1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28473412      PMCID： PMC5418641          DOI： 10.1182/blood-2017-03-772087

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.

Authors:  Berhane Ghebrehiwet; Claudia CebadaMora; Lee Tantral; Jolyon Jesty; Ellinor I B Peerschke
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

2.  Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Justin Paul; Erin H Norris; Robert Bronstein; Hyung Jin Ahn; Daria Zamolodchikov; Shivaprasad Bhuvanendran; Katherine M Fenz; Sidney Strickland
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

3.  Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.

Authors:  Zu-Lin Chen; Alexey S Revenko; Pradeep Singh; A Robert MacLeod; Erin H Norris; Sidney Strickland
Journal:  Blood       Date:  2017-02-27       Impact factor: 22.113

4.  The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.

Authors:  D Zamolodchikov; T Renné; S Strickland
Journal:  J Thromb Haemost       Date:  2016-02-29       Impact factor: 5.824

Review 5.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

6.  Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.

Authors:  Jae Kyu Ryu; Mark A Petersen; Sara G Murray; Kim M Baeten; Anke Meyer-Franke; Justin P Chan; Eirini Vagena; Catherine Bedard; Michael R Machado; Pamela E Rios Coronado; Thomas Prod'homme; Israel F Charo; Hans Lassmann; Jay L Degen; Scott S Zamvil; Katerina Akassoglou
Journal:  Nat Commun       Date:  2015-09-10       Impact factor: 14.919

7.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.

Authors:  Dimitrios Davalos; Jae Kyu Ryu; Mario Merlini; Kim M Baeten; Natacha Le Moan; Mark A Petersen; Thomas J Deerinck; Dimitri S Smirnoff; Catherine Bedard; Hiroyuki Hakozaki; Sara Gonias Murray; Jennie B Ling; Hans Lassmann; Jay L Degen; Mark H Ellisman; Katerina Akassoglou
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 8.  Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.

Authors:  Sophia Bardehle; Victoria A Rafalski; Katerina Akassoglou
Journal:  Front Cell Neurosci       Date:  2015-09-16       Impact factor: 5.505

9.  A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.

Authors:  Hyung Jin Ahn; J Fraser Glickman; Ka Lai Poon; Daria Zamolodchikov; Odella C Jno-Charles; Erin H Norris; Sidney Strickland
Journal:  J Exp Med       Date:  2014-05-12       Impact factor: 14.307
  9 in total
  4 in total

Review 1.  Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome.

Authors:  Sana Khan; Soumya Pati; Shailja Singh; Mohd Akhtar; Piush Khare; Saba Khan; Sadat Shafi; Abul Kalam Najmi
Journal:  Int J Obes (Lond)       Date:  2021-10-22       Impact factor: 5.095

2.  Plasma contact factors as novel biomarkers for diagnosing Alzheimer's disease.

Authors:  Jung Eun Park; Do Sung Lim; Yeong Hee Cho; Kyu Yeong Choi; Jang Jae Lee; Byeong C Kim; Kun Ho Lee; Jung Sup Lee
Journal:  Biomark Res       Date:  2021-01-09

Review 3.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.

Authors:  Mark A Petersen; Jae Kyu Ryu; Katerina Akassoglou
Journal:  Nat Rev Neurosci       Date:  2018-04-05       Impact factor: 34.870

4.  Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.

Authors:  Srabani Kar; Madhusoodanan Mottamal; Rami A Al-Horani
Journal:  ChemistryOpen       Date:  2020-11-10       Impact factor: 2.630
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.